SPARC
Invest Now
Sun Pharma Advanced Research Company Share Price
₹194.36 -3.02 (-1.53%)
18 Nov, 2024 17:12
Start SIP in SPARC
Start SIPPerformance
- Low
- ₹193
- High
- ₹200
- 52 Week Low
- ₹193
- 52 Week High
- ₹473
- Open Price₹198
- Previous Close₹197
- Volume390,106
Investment Returns
- Over 1 Month -7.46%
- Over 3 Month -8.88%
- Over 6 Month -10.14%
- Over 1 Year -21.77%
Smart Investing Starts Here Start SIP with Sun Pharma Advanced Research Company for Steady Growth!
Sun Pharma Advanced Research Company Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -15.4
- PEG Ratio
- -
- Market Cap Cr
- 6,307
- P/B Ratio
- 50.2
- Average True Range
- 7.45
- EPS
- 0
- Dividend Yield
- 0
- MACD Signal
- -1.77
- RSI
- 35.3
- MFI
- 35.91
Sun Pharma Advanced Research Company Financials
Sun Pharma Advanced Research Company Technicals
EMA & SMA
Current Price
₹194.36
-3.02
(-1.53%)
- Bullish Moving Average 0
- Bearish Moving Average 16
- 20 Day
- ₹208.13
- 50 Day
- ₹213.13
- 100 Day
- ₹224.17
- 200 Day
- ₹240.95
Resistance and Support
197.2
- R3 209.71
- R2 205.48
- R1 201.43
- S1 193.15
- S2 188.92
- S3 184.87
Sun Pharma Advanced Research Company Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-04 | Quarterly Results | |
2024-08-05 | Quarterly Results | |
2024-05-24 | Audited Results | |
2024-02-05 | Quarterly Results | |
2023-11-06 | Quarterly Results |
Sun Pharma Advanced Research Company F&O
About Sun Pharma Advanced Research Company
- NSE Symbol
- SPARC
- BSE Symbol
- 532872
- ISIN
- INE232I01014
Similar Stocks to Sun Pharma Advanced Research Company
Sun Pharma Advanced Research Company FAQs
Sun Pharma Advanced Research Company share price is ₹194 As on 18 November, 2024 | 16:58
The Market Cap of Sun Pharma Advanced Research Company is ₹6307.4 Cr As on 18 November, 2024 | 16:58
The P/E ratio of Sun Pharma Advanced Research Company is -15.4 As on 18 November, 2024 | 16:58
The PB ratio of Sun Pharma Advanced Research Company is 50.2 As on 18 November, 2024 | 16:58
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.